Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty: Results of Separate Pooled Analyses of Phase III Multicenter Randomized Trials

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Circulation. Cardiovascular Quality and Outcomes

• Publication date

  2010-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCOUTCOMES.110.957712PMID 20923996
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.

  2010cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.

  2009cited by this paper
• Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.

  2009cited by this paper
• Use of tumour-responsive T cells as cancer treatment.

  2009cited by this paper
• Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

  2009cited by this paper
• Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study

  2009cited by this paper
• State-of-the-Art Review: Assessing the Safety Profiles of New Anticoagulants for Major Orthopedic Surgery Thromboprophylaxis

  2009cited by this paper
• Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.

  2008cited by this paper
• Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Chapter 9: Analysing Data and Undertaking Meta-Analyses

  2008cited by this paper
• Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.

  2008cited by this paper
• Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.

  2008cited by this paper
• Mandated venous thromboembolism prophylaxis: possible adverse outcomes.

  2008cited by this paper
• Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

  2007cited by this paper
• Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.

  2007cited by this paper
• Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry.

  2007cited by this paper
• Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery

  2007cited by this paper
• A Once-Daily, Oral, Direct Factor Xa Inhibitor, Rivaroxaban (BAY 59-7939), for Thromboprophylaxis After Total Hip Replacement

  2006cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.

  2002cited by this paper
• Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.

  2002cited by this paper
• Prevention of venous thromboembolism.

  2001cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Effect of Oral Direct Factor Xa Inhibitors on the Prevalence of Hip Heterotopic Ossification following Arthroplasty for Acute Femoral Neck Fracture: A Propensity Score-Matched Cohort Study.

  2025cites this paper
• Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair.

  2025cites this paper
• The safety and efficacy of NOACs versus LMWH for thromboprophylaxis after THA or TKA: A systemic review and meta-analysis.

  2024cites this paper
• Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors

  2023cites this paper
• Current Evidence and Expert Opinion on Thromboprophylaxis After Total Knee and Hip Replacement

  2023cites this paper
• Efficacy and Safety of Enoxaparin versus New Oral Anticoagulants to Prevent Venous Thromboembolism after Total Hip Replacement: A Systematic Review and Meta-Analysis

  2022cites this paper
• Recommendations from the ICM-VTE: Hip & Knee.

  2022cites this paper
• Prevention of thromboembolism in orthopedic surgery: Application of rivaroxaban in arthroplastic procedures

  2022cites this paper
• Association between duration of anticoagulant thromboprophylaxis and revision rate in primary total hip arthroplasty: a Danish and Norwegian nationwide cohort study

  2022cites this paper
• Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study

  2021cites this paper
• Methods of Venous Thromboembolic Prophylaxis in Orthopedic Surgeries

  2020cites this paper
• Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery

  2020cites this paper
• Research Paper: Comparing Prophylactic Effect of Rivaroxaban and Enoxaparin on Thromboembolism After Total Hip or Knee Arthroplasty

  2020cites this paper
• Practice patterns for extended venous thromboembolism chemoprophylaxis among urologic oncologists after radical cystectomy.

  2020cites this paper
• A Prospective Cohort Comparative Study of Rivaroxaban, Dabigatran, and Apixaban Oral Thromboprophylaxis in 2431 Hip and Knee Arthroplasty Patients: Primary Efficacy Outcomes and Safety Profile.

  2020cites this paper
• Aspirin for venous thromboembolism prophylaxis after hip or knee arthroplasty: An updated meta-analysis of randomized controlled trials.

  2019cites this paper
• Aspirin for venous thromboembolism prophylaxis after hip or knee arthroplasty: An updated meta-analysis of randomized controlled trials.

  2019cites this paper
• Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.

  2019cites this paper
• VTE Prophylaxis in General and Orthopedic Surgery

  2019cites this paper
• Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis

  2018cites this paper
• Use of direct oral anticoagulants in daily practice.

  2018cites this paper
• Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total knee arthroplasty

  2018cites this paper
• Similar thromboprophylaxis with rivaroxaban and low molecular weight heparin but fewer hemorrhagic complications with combined intra-articular and intravenous tranexamic acid in total knee arthroplasty

  2018cites this paper
• Direct Oral Anticoagulants Vs. Enoxaparin for Prevention of Venous Thromboembolism Following Orthopedic Surgery: A Dose–Response Meta‐analysis

  2017cites this paper
• The role of new oral anticoagulants in orthopaedics: an update of recent evidence

  2017cites this paper
• Efficacy and safety of new oral anticoagulants in the prevention of venous thromboembolism after orthopaedic surgery and their impact on the subsequent quality of life

  2017cites this paper
• 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force.

  2017cites this paper
• Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis

  2016cites this paper
• Efficacy and safety of rivaroxaban thromboprophylaxis after arthroplasty of the hip or knee: retrospective cohort study.

  2016cites this paper
• Effectiveness and Safety of Fixed-Dose Tranexamic Acid in Simultaneous Bilateral Total Knee Arthroplasty: A Randomized Double-Blind Controlled Trial.

  2016cites this paper
• Patient compliance with new oral anticoagulants after major orthopaedic surgery: rivaroxaban and dabigatran compared with subcutaneous injection of fondaparinux

  2016influential citation
• Russian Experience of the Rational Thromboprophylaxis in Traumatology and Orthopaedics

  2016cites this paper
• Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis.

  2015cites this paper
• Clinical Experience With Novel Oral Anticoagulants for Thromboprophylaxis After Elective Hip and Knee Arthroplasty

  2015cites this paper
• Rivaroxaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis after Hip and Knee Arthroplasty.

  2015cites this paper
• Russian Experience in Rational Thromboprophylaxis in Traumatology and Orthopaedics

  2015cites this paper
• Oral thromboprophylaxis in patients with ankle fractures immobilized in a below the knee cast.

  2015cites this paper
• New Prospective for theManagement of Low-Risk Pulmonary Embolism : Prognostic Assessment , Early Discharge , and Single-Drug Therapy with NewOral Anticoagulants

  2014cites this paper
• The need to clot: a review of current management strategies for adverse bleeding events with new oral anticoagulants.

  2014cites this paper
• Consensus of the Orthopedic Anesthesia, Pain, and Rehabilitation Society on the use of peripheral nerve blocks in patients receiving thromboprophylaxis.

  2014cites this paper
• Venous thromboembolic prophylaxis after total joint arthroplasty

  2014cites this paper
• [Prevention of venous thromboembolism in musculoskeletal surgery].

  2014influential citation
• New oral anticoagulants and their implications for dental patients.

  2014cites this paper
• Deep vein thrombosis and novel oral anticoagulants: a clinical review.

  2013cites this paper
• Idraparinux or Idrabiotaparinux for Long-Term Venous Thromboembolism Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2013cites this paper
• Prevention and Treatment of Venous Thromboembolism with New Oral Anticoagulants: A Practical Update for Clinicians

  2013cites this paper
• Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology.

  2013cites this paper
• Direct treatment comparison of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after total knee arthroplasty surgery: design of a randomised pilot study (DARINA)

  2013cites this paper
• The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty

  2013cites this paper
• Thromboprophylaxis for Deep Vein Thrombosis and Pulmonary Embolism after Total Joint Arthroplasty in a Low Incidence Population

  2013cites this paper
• Apixaban and rivaroxaban decrease deep venous thrombosis but not other complications after total hip and total knee arthroplasty.

  2013cites this paper
• Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.

  2013cites this paper
• New oral anticoagulants: prevention of VTE in phase III studies in total joint replacement surgery and the hospitalized medically-ill patients

  2013cites this paper
• The use of novel oral anticoagulants for

  2013cites this paper
• Rivaroxaban frente a heparinas de bajo peso molecular para la prevención de la tromboembolia venosa posterior al reemplazo total de cadera o rodilla: revisión sistemática de la literatura y metaanálisisis

  2013cites this paper
• Preventing venous thromboembolism in major orthopaedic surgery

  2013cites this paper
• Haemostatic challenges in the cancer patient: focus on the perioperative period.

  2013cites this paper
• The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery

  2013cites this paper
• University of Groningen Direct treatment comparison of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after total knee arthroplasty surgery

  2013cites this paper
• Venous thromboembolism (VTE) prevention in orthopedics: facts, controversies, and evolving management

  2012cites this paper
• Breakthroughs in anticoagulation: advent of the oral direct factor Xa inhibitors.

  2012cites this paper
• Most Important Outcomes Research Papers on Anticoagulation for Cardiovascular Disease

  2012cites this paper
• Bleeding definitions in orthopaedic VTE prophylaxis trials: a real need for standardization.

  2012cites this paper
• New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders

  2012cites this paper
• New oral anticoagulants: will they replace warfarin?

  2012cites this paper
• A new approach with anticoagulant development: tailoring anticoagulant therapy with dabigatran etexilate according to patient risk

  2012cites this paper
• Dabigatran Etexilate

  2012cites this paper
• Apixaban: a novel oral inhibitor of factor Xa.

  2012cites this paper
• Performance of New Anticoagulants for Thromboprophylaxis in Patients Undergoing Hip and Knee Replacement Surgery

  2012cites this paper
• New Prospective for the Management of Low-Risk Pulmonary Embolism: Prognostic Assessment, Early Discharge, and Single-Drug Therapy with New Oral Anticoagulants

  2012cites this paper
• Dabigatran etexilate: an oral direct thrombin inhibitor for the management of thromboembolic disorders.

  2012cites this paper
• A PRIMARY TEST OF COMBINED THROMBOPROPHYLAXIS AT LOWER EXTREMITIES ARTHROPLASTY: ASPECTS AND VARIANTS OF USAGE

  2012cites this paper
• Oral Direct Thrombin Inhibitors and Oral Factor Xa Inhibitors

  2012cites this paper
• MEDICAL MANAGEMENT AND PHARMACOLOGY UPDATE New oral anticoagulants: will they replace warfarin?

  2012cites this paper
• [New advances in anticoagulation: is it time to forget about heparin and vitamin K antagonists? Yes].

  2012cites this paper
• Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants

  2011cites this paper
• Editor's Perspective Outcomes Research in the Global Environment Learning From Each Other

  2011cites this paper
• Outcomes research in the global environment: learning from each other.

  2011cites this paper
• Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism.

  2011cites this paper
• prevention and Treatment of Venous Thromboembolic events: Focus on Dabigatran etexilate

  2011cites this paper
• Old and new anticoagulants

  2011cites this paper
• A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery

  2011cites this paper
• Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.

  2011cites this paper
• The proof for new oral anticoagulants: clinical trial evidence

  2011cites this paper
• New insights on the role of direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery

  2011cites this paper
• Inhibitors of propagation of coagulation: factors V and X.

  2011cites this paper
• Dabigatran: Will it change clinical practice?

  2011cites this paper
• New aspects on treatment modalities for thromboembolic episodes

  2010cites this paper